TrialCancer prevention research (Philadelphia, Pa.)2009

Phase II randomized, placebo-controlled trial of green tea extract in patients with high-risk oral premalignant lesions.

Anne S Tsao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.